Medical Affairs leaders have become increasingly familiar with a difficult moment in performance reviews: a slide appears showing hundreds of healthcare professional interactions, multiple advisory boards, numerous scientific presentations, and a high volume of medical enquiries- followed by the unspoken question, “But what changed?”

Traditional Medical Affairs measurement has often been built around activity. Numbers of engagements, events, presentations, enquiries, and interactions were relatively straightforward to capture and easy to compare across teams or reporting periods. These measures were useful for understanding workload and execution, but they offered limited insight into whether Medical Affairs activity created meaningful scientific or strategic value.

The focus is gradually shifting from counting interactions to understanding engagement quality, stakeholder perceptions, insight utilisation, scientific influence, and contribution to organisational decisions. The transition from volume to value does not mean abandoning activity metrics. It means recognising what they actually measure. Activity metrics demonstrate effort. Value metrics demonstrate effect. Medical Affairs needs both, but the two should no longer be treated as interchangeable.

The Limitations of Traditional MA KPIs

Legacy KPIs remain useful for operational management. Numbers of HCP interactions, advisory boards, scientific presentations, and Medical Information responses can help assess workload, resource requirements, geographic coverage, and whether planned activities were delivered.

The problem begins when these measures are used as evidence of impact. Consider a team that completes six advisory boards has clearly delivered six activities, but the number alone says nothing about what those advisory boards achieved. Two may have identified important evidence gaps that changed the evidence-generation plan, while others may have generated useful discussion but no subsequent strategic action. Counting them equally conceals the difference that matters most.

Similarly, the number of HCP interactions provides little information about the quality of those engagements. A ten-minute introductory conversation and a detailed scientific discussion resulting in a follow-up research collaboration may both appear as one interaction in a conventional dashboard.

Activity-based KPIs also create difficulty when Medical Affairs needs to demonstrate alignment with broader organisational priorities. Leadership increasingly wants to understand how Medical Affairs contributes to evidence generation, scientific strategy, stakeholder understanding, research priorities, education, and ultimately better-informed healthcare decisions.

These contributions rarely appear directly in an activity count. There is therefore a fundamental distinction between two questions. Traditional KPIs ask, “Did the team do the work?” Modern Medical Affairs measurement must also ask, “What effect did the work have?” The first question remains important for operational management. The second is essential for demonstrating strategic value.

The Rise of Meaningful Medical Affairs KPIs

Phase 1: Measuring Engagement Quality

The first step beyond activity counting is understanding the quality and depth of stakeholder engagement. Rather than simply recording the number of KOL meetings, teams can assess whether those interactions led to meaningful next steps. Follow-up requests, additional scientific questions, proposed collaborations, evidence discussions, or invitations to continue the conversation can all provide indications that an engagement moved beyond a one-time interaction. For example, instead of reporting that 40 KOL meetings took place during a quarter, a Medical Affairs team might report that 12 resulted in documented follow-up actions, including requests for additional data, discussion of potential research collaboration, or further scientific exchange.

Engagement quality can also include stakeholder sentiment, relevance of the scientific discussion, and alignment with HCP needs. These measures do not need to become overly complicated. The most important step is defining what a meaningful interaction looks like before measurement begins.

Depth is particularly important because increasing the number of interactions does not automatically increase value. In some therapeutic areas, fewer but more scientifically substantive engagements may contribute more to strategy than a much larger number of brief contacts.

The objective should therefore be to understand not only how often Medical Affairs engages, but whether those interactions progress scientific relationships and improve understanding of stakeholder needs.

Phase 2: Capturing Scientific Insights

Medical Affairs field teams generate a considerable amount of scientific intelligence through their interactions with clinicians, researchers, and other stakeholders. However, simply counting the number of insights captured creates the same problem as counting engagements: volume does not necessarily indicate usefulness.

A stronger KPI evaluates what happens after an insight enters the organisation. The journey can be viewed as a sequence: insight captured → insight shared → insight evaluated → insight acted upon.

The drop-off between these stages often reveals more about Medical Affairs effectiveness than the original number of insights collected. For example, a field team may document 90 insights during a quarter. Reporting the number alone might suggest strong performance. A more meaningful measurement could show that several recurring themes were identified, seven insights were incorporated into the evidence-generation plan, and two directly influenced discussion around future study endpoints.

Those numbers demonstrate scientific influence rather than simple collection activity. Insight quality also depends on consistency. Teams need a clear definition of what constitutes an actionable insight. Without one, different MSLs or markets may record fundamentally different types of information under the same label, making comparisons unreliable. The strongest insight KPIs therefore evaluate relevance, actionability, recurrence, strategic adoption, and the degree to which field intelligence contributes to internal decision-making.

Phase 3: Demonstrating Outcomes and Influence

Outcome measurement is the most challenging stage because Medical Affairs rarely acts in isolation. Changes in scientific understanding, clinical discussion, treatment behaviour, research priorities, or educational needs may result from multiple influences. Publications, congresses, guidelines, peer discussion, clinical experience, and Medical Affairs engagement can all contribute. For this reason, Medical Affairs should generally focus on contribution rather than attribution.

The aim is not to claim that a single MSL conversation caused a clinical or organisational outcome. Instead, teams can document credible evidence that Medical Affairs contributed to a measurable change. For example, following a series of scientific educational interactions, a KOL network may demonstrate a clearer understanding of treatment sequencing in subsequent congress discussions or advisory activities. Medical Affairs cannot reasonably claim sole responsibility for that change. However, a documented before-and-after assessment combined with a clear record of scientific engagement can demonstrate a credible contribution.

Quantitative measures become more powerful when paired with a concise narrative explaining the pathway from activity to outcome. This combination helps leadership understand not only what changed, but how Medical Affairs plausibly contributed to that change.

Outcome-based KPIs therefore require more judgement than traditional activity metrics, but they are also far more capable of demonstrating strategic relevance.

Enablers of Modern KPI Measurement

Modern Medical Affairs measurement depends on three core enablers: people, processes, and technology.

People remain the starting point. Medical Affairs, analytics, data, and digital teams need to collaborate on KPI design, but ownership of the definition of value should remain firmly connected to Medical Affairs strategy. A common pitfall is handing KPI development entirely to analytics teams. Analysts may naturally prioritise measures that are easy to extract, standardise, and display. These measures can be technically robust but scientifically meaningless if they do not reflect the purpose of Medical Affairs. Measurement expertise and scientific context therefore need to work together.

Processes create consistency. Standard definitions are required for concepts such as meaningful engagement, actionable insight, stakeholder impact, and strategic adoption. If each region or team defines these differently, aggregated performance figures become difficult to interpret. An “actionable insight,” for instance, should mean approximately the same thing across teams. Without a shared definition, one group may record every HCP observation as an insight while another records only observations that influence strategy. The resulting numbers cannot be meaningfully compared.

KPI frameworks should also evolve. Metrics that were appropriate during launch may be less useful during a mature product phase, while different therapeutic areas may require different measures of scientific value. Regular KPI review should therefore form part of the measurement process.

Technology enables scale and visibility. CRM systems, digital engagement platforms, AI-supported analytics, sentiment analysis, real-time dashboards, and integrated data environments can connect activities with downstream outcomes more effectively than traditional spreadsheets. However, technology cannot correct the wrong measurement model. A sophisticated dashboard containing only interaction counts remains an activity dashboard. New tools can display weak KPIs faster, but they cannot transform them into meaningful measures of value.

The sequence should therefore remain clear: define value first, standardise the methodology second, and automate measurement third.

Measuring Productivity and Impact

A modern Medical Affairs scorecard should balance activity with a smaller number of meaningful value indicators. Engagement-quality measures can show whether stakeholder interactions are relevant and productive. Insight-utilisation measures can demonstrate whether field intelligence reaches internal teams and influences decisions. Outcome and influence measures can provide evidence that Medical Affairs is contributing to scientific strategy, evidence generation, stakeholder understanding, or healthcare initiatives.

A practical approach is to begin with one metric at each level rather than attempting to redesign the entire performance framework at once. For example, a quarterly Medical Affairs scorecard might report that 30% of priority KOL engagements led to a documented follow-up action, eight field insights were incorporated into medical strategy, and one evidence gap identified through Medical Affairs engagement progressed into a new study concept.

Only three numbers are presented, but each answers the question that activity counts often cannot: What changed because Medical Affairs was involved?

Digital analytics can strengthen this model by linking interactions, insights, and subsequent actions across systems. Over time, teams can identify which engagement approaches generate the most useful insights, which stakeholder groups contribute most to strategic learning, and where scientific interactions appear to have the greatest downstream influence.

Productivity should therefore not be interpreted simply as producing more activity with the same resources. In Medical Affairs, higher productivity increasingly means generating greater scientific value from each activity undertaken.

Conclusion: From Activity Tracking to Strategic Measurement

Medical Affairs measurement is moving from a model dominated by activity counts towards one that increasingly evaluates quality, insight, influence, and outcomes. Legacy metrics still have a role. Interaction numbers, advisory board counts, enquiry volumes, and scientific presentations help teams understand workload and execution. The mistake is not collecting these measures; it is assuming that they demonstrate value on their own.

Meaningful Medical Affairs KPIs go beyond documenting activity to demonstrate how engagement creates value. They capture whether scientific interactions strengthen stakeholder relationships, whether field insights shape strategy, whether unmet evidence needs are recognised, and how Medical Affairs contributes to improved scientific understanding and more informed decision-making.

Digital platforms and analytics can make these connections increasingly visible, but the underlying question remains human and strategic. Medical Affairs leaders must first define what value means before technology can help measure it. The shift does not require measuring everything. It requires changing the question. The goal is not to ask only how much Medical Affairs did, but what changed because Medical Affairs did it.